CD79A and systemic lupus erythematosus: Isolated IgA anti-β2GPI was associated with an increased risk of thromboembolic events in the 56 patients with and without SLE (p = 0.018, odds ratio [OR] = 2.793, 95% confidence interval [CI] = 1.263–6.172).